Last reviewed · How we verify

NCT05497440

Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.

Withdrawn NA Last updated 31 January 2025
What this trial tests

NA trial testing All'InCath CBC 035M Balloon Dilatation Catheter in Vascular Diseases. Withdrawn.

Timeline
7 July 2022
Primary endpoint
7 October 2022
7 October 2022

Quick facts

Lead sponsorNexStep Medical
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date7 July 2022
Primary completion7 October 2022
Estimated completion7 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

NexStep Medical

Who can join

18 and older, any sex, with Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this post-market clinical study is to obtain additional data on the safety and performance of the All'InCath 035M Balloon Dilatation Catheter when used per its Instructions for Use (IFU) during percutaneous transluminal angioplasty procedures in clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of All'InCath CBC 035M Balloon Dilatation Catheter

Trials testing the same drug.

Other recruiting trials for Vascular Diseases

Currently open trials in the same condition.

Other NexStep Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05497440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing